NUTCRACKER

Waren und Dienstleistungen

01 Active chemical ingredients, including m-RNA, for use in the manufacture of anti-cancer drugs; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with transcription and translation of nucleic acid; chemical solutions and preparations consisting of pre-mixed reactants and reagents used to transfect nucleic acid into cells in the field of scientific research; active chemical ingredients for use in manufacture of anti-cancer drugs; protein arrays and nucleotide arrays for scientific use; nucleic acids, proteins and peptides for laboratory use; diagnostic preparations for scientific or research use other than for medical purposes; macromolecules, namely, nucleic acid sequences and proteins, used for pharmaceutical manufacturing and scientific purposes

05 Macromolecules, namely, nucleic acid sequences and proteins, used for medical purposes; nucleic acid sequences and chemical reagents for medical purposes; protein arrays and nucleotide arrays for medical laboratory use; diagnostic preparations for clinical or medical laboratory use

09 Cartridges and DNA chips to receive and preserve biological samples for use in RNA transcription; scientific apparatus and instruments for manufacturing m-RNA and parts and fittings therefore; laboratory apparatus and instruments for transcription of RNA from DNA and translation to m-RNA; scientific apparatus for receiving DNA samples, transcribing RNA, and producing m-RNA molecules for use in identifying and/or manufacturing therapeutic drugs to treat human diseases

35 Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; compiling data for research purposes in the field of medical science and medical consultancy

42 Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic sciences; DNA analysis services for scientific research purposes; medical and scientific research, in particular in the fields of prevention and treatment cancer; providing scientific research information, consultancy, and advisory services, in particular in the fields of prevention and treatment of cancer treatment; conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; and consulting services for others in the field of design, planning, and implementation of clinical trials; design, engineering, research, development and testing services in the field of nucleic acid sciences for medical, scientific and technological applications; scientific research; scientific research in the fields of pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics

44 Medical services, in particular providing therapy and vaccination approaches for treating and preventing cancer, infectious diseases and immunological diseases; veterinary services, in particular providing therapy and vaccination approaches for treating and preventing cancer, infectious diseases, and immunological diseases; medical, veterinary and pharmaceutical consultation; medical and veterinary diagnostic testing, monitoring and reporting services; providing medical information, consultancy, and advisory services, in particular in the fields of treatment and prevention of immunological diseases, cancer treatment, prevention of cancer, treatment of infectious diseases, and prevention of infectious diseases; medical services, namely, providing therapies for treating cancer, medical and pharmaceutical consultation; medical diagnostic testing, monitoring and reporting services; genetic testing for medical purposes

Übersetzung anzeigen

Markenhistorie

Datum	Belegnummer	Bereich	Eintrag
13. März 2023	2023/11 Gaz	KR	RAW: Rule 18ter(2)(ii) GP following a provisional refusal
25. Januar 2023	2023/4 Gaz	MY	Ablehnung
17. Januar 2023	2023/6 Gaz	SG	RAW: Rule 18ter(2)(ii) GP following a provisional refusal
17. November 2022	2022/46 Gaz	CA	Ablehnung
03. November 2022	2022/45 Gaz	JP	RAW: Rule 18ter(2)(ii) GP following a provisional refusal
19. September 2022	2022/42 Gaz	IN	RAW: Rule 18ter(2)(ii) GP following a provisional refusal
16. September 2022	2022/37 Gaz	AU	RAW: Rule 18ter(2)(i) GP following a provisional refusal
19. August 2022	2022/34 Gaz	ID	Ablehnung
04. August 2022	2022/31 Gaz	KR	Ablehnung
28. Juni 2022	2022/26 Gaz	CH	Ablehnung
11. Mai 2022	2022/19 Gaz	GB	Ablehnung
28. April 2022	2022/17 Gaz	JP	Ablehnung
01. März 2022	2022/9 Gaz	CN	Ablehnung
04. Januar 2022	2022/1 Gaz	EM	Ablehnung
02. Oktober 2021	2021/41 Gaz	SG	Ablehnung
19. August 2021	2021/34 Gaz	IN	Ablehnung
14. August 2021	2021/33 Gaz	AU	Ablehnung
17. März 2021	2021/29 Gaz	US	Eintragung

Markenform	Bildmarke
Aktenzeichen	1605646
Länder
Basismarke	Nr. , 17. Oktober 2024

Anmeldedatum	17. März 2021
Ablaufdatum	17. März 2031

Schützen Sie diese Marke vor Nachahmern!

Markendetails Letztes Update: 30. Juni 2023

Markeninhaber

Markenvertreter

Waren und Dienstleistungen

Markenhistorie